Somerset Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Somerset Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-100	Closed	-$4K	–	200
2013 Q4	$4K	Buy	+100	New	+$3.94K	﹤0.01%	185

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Somerset Trust's TEVA Position: Q1 2014 in Review

Somerset Trust sold out of Teva Pharmaceuticals (TEVA) in Q1 2014, closing a stake of 100 shares — an estimated $4K sold.

Somerset Trust first reported a position in TEVA in Q4 2013 and held it in 1 quarter. The position peaked at $4K in Q4 2013. 770 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

Somerset Trust reported no remaining Teva Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
Somerset Trust sold 100 Teva Pharmaceuticals shares in Q1 2014, an estimated $4K.
Somerset Trust first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 1 quarter.
Somerset Trust's Teva Pharmaceuticals position peaked at $4K in Q4 2013.
770 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2014.

Based on Somerset Trust's 13F filing for Q1 2014, filed 9 Apr 2014.